0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
AI-Assisted Diagnosis in Neurology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-36G8691
Home | Market Reports | Health| Medical Facilities & Services
Global AI Assisted Diagnosis in Neurology Market Insights Forecast to 2028
BUY CHAPTERS

AI-Assisted Diagnosis in Neurology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-36G8691
Report
October 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI-Assisted Diagnosis in Neurology - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

AI-Assisted Diagnosis in Neurology - Market

AI-Assisted Diagnosis in Neurology - Market

The global market for AI-Assisted Diagnosis in Neurology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for AI-Assisted Diagnosis in Neurology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI-Assisted Diagnosis in Neurology by region & country, by Type, and by Application.
The AI-Assisted Diagnosis in Neurology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-Assisted Diagnosis in Neurology.
Market Segmentation

Scope of AI-Assisted Diagnosis in Neurology - Market Report

Report Metric Details
Report Name AI-Assisted Diagnosis in Neurology - Market
CAGR 5%
Segment by Type:
  • Hardware
  • Software
Segment by Application
  • Visualization Analysis
  • Diagnoses
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioMind, Arterys, Brain Scientific, Methinks, Neuro-AI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of AI-Assisted Diagnosis in Neurology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of AI-Assisted Diagnosis in Neurology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of AI-Assisted Diagnosis in Neurology in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the AI-Assisted Diagnosis in Neurology - Market report?

Ans: The main players in the AI-Assisted Diagnosis in Neurology - Market are BioMind, Arterys, Brain Scientific, Methinks, Neuro-AI

What are the Application segmentation covered in the AI-Assisted Diagnosis in Neurology - Market report?

Ans: The Applications covered in the AI-Assisted Diagnosis in Neurology - Market report are Visualization Analysis, Diagnoses, Others

What are the Type segmentation covered in the AI-Assisted Diagnosis in Neurology - Market report?

Ans: The Types covered in the AI-Assisted Diagnosis in Neurology - Market report are Hardware, Software

Recommended Reports

AI Diagnostics Solutions

Neurology & CNS Markets

AI Drug Development

1 Market Overview
1.1 AI-Assisted Diagnosis in Neurology Product Introduction
1.2 Global AI-Assisted Diagnosis in Neurology Market Size Forecast
1.3 AI-Assisted Diagnosis in Neurology Market Trends & Drivers
1.3.1 AI-Assisted Diagnosis in Neurology Industry Trends
1.3.2 AI-Assisted Diagnosis in Neurology Market Drivers & Opportunity
1.3.3 AI-Assisted Diagnosis in Neurology Market Challenges
1.3.4 AI-Assisted Diagnosis in Neurology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AI-Assisted Diagnosis in Neurology Players Revenue Ranking (2023)
2.2 Global AI-Assisted Diagnosis in Neurology Revenue by Company (2019-2024)
2.3 Key Companies AI-Assisted Diagnosis in Neurology Manufacturing Base Distribution and Headquarters
2.4 Key Companies AI-Assisted Diagnosis in Neurology Product Offered
2.5 Key Companies Time to Begin Mass Production of AI-Assisted Diagnosis in Neurology
2.6 AI-Assisted Diagnosis in Neurology Market Competitive Analysis
2.6.1 AI-Assisted Diagnosis in Neurology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by AI-Assisted Diagnosis in Neurology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-Assisted Diagnosis in Neurology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hardware
3.1.2 Software
3.2 Global AI-Assisted Diagnosis in Neurology Sales Value by Type
3.2.1 Global AI-Assisted Diagnosis in Neurology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global AI-Assisted Diagnosis in Neurology Sales Value, by Type (2019-2030)
3.2.3 Global AI-Assisted Diagnosis in Neurology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Visualization Analysis
4.1.2 Diagnoses
4.1.3 Others
4.2 Global AI-Assisted Diagnosis in Neurology Sales Value by Application
4.2.1 Global AI-Assisted Diagnosis in Neurology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global AI-Assisted Diagnosis in Neurology Sales Value, by Application (2019-2030)
4.2.3 Global AI-Assisted Diagnosis in Neurology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global AI-Assisted Diagnosis in Neurology Sales Value by Region
5.1.1 Global AI-Assisted Diagnosis in Neurology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global AI-Assisted Diagnosis in Neurology Sales Value by Region (2019-2024)
5.1.3 Global AI-Assisted Diagnosis in Neurology Sales Value by Region (2025-2030)
5.1.4 Global AI-Assisted Diagnosis in Neurology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
5.2.2 North America AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
5.3.2 Europe AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
5.4.2 Asia Pacific AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
5.5.2 South America AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
5.6.2 Middle East & Africa AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI-Assisted Diagnosis in Neurology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions AI-Assisted Diagnosis in Neurology Sales Value
6.3 United States
6.3.1 United States AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
6.3.2 United States AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States AI-Assisted Diagnosis in Neurology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
6.4.2 Europe AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe AI-Assisted Diagnosis in Neurology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
6.5.2 China AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
6.5.3 China AI-Assisted Diagnosis in Neurology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
6.6.2 Japan AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan AI-Assisted Diagnosis in Neurology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
6.7.2 South Korea AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea AI-Assisted Diagnosis in Neurology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
6.8.2 Southeast Asia AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia AI-Assisted Diagnosis in Neurology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India AI-Assisted Diagnosis in Neurology Sales Value, 2019-2030
6.9.2 India AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
6.9.3 India AI-Assisted Diagnosis in Neurology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioMind
7.1.1 BioMind Profile
7.1.2 BioMind Main Business
7.1.3 BioMind AI-Assisted Diagnosis in Neurology Products, Services and Solutions
7.1.4 BioMind AI-Assisted Diagnosis in Neurology Revenue (US$ Million) & (2019-2024)
7.1.5 BioMind Recent Developments
7.2 Arterys
7.2.1 Arterys Profile
7.2.2 Arterys Main Business
7.2.3 Arterys AI-Assisted Diagnosis in Neurology Products, Services and Solutions
7.2.4 Arterys AI-Assisted Diagnosis in Neurology Revenue (US$ Million) & (2019-2024)
7.2.5 Arterys Recent Developments
7.3 Brain Scientific
7.3.1 Brain Scientific Profile
7.3.2 Brain Scientific Main Business
7.3.3 Brain Scientific AI-Assisted Diagnosis in Neurology Products, Services and Solutions
7.3.4 Brain Scientific AI-Assisted Diagnosis in Neurology Revenue (US$ Million) & (2019-2024)
7.3.5 Methinks Recent Developments
7.4 Methinks
7.4.1 Methinks Profile
7.4.2 Methinks Main Business
7.4.3 Methinks AI-Assisted Diagnosis in Neurology Products, Services and Solutions
7.4.4 Methinks AI-Assisted Diagnosis in Neurology Revenue (US$ Million) & (2019-2024)
7.4.5 Methinks Recent Developments
7.5 Neuro-AI
7.5.1 Neuro-AI Profile
7.5.2 Neuro-AI Main Business
7.5.3 Neuro-AI AI-Assisted Diagnosis in Neurology Products, Services and Solutions
7.5.4 Neuro-AI AI-Assisted Diagnosis in Neurology Revenue (US$ Million) & (2019-2024)
7.5.5 Neuro-AI Recent Developments
8 Industry Chain Analysis
8.1 AI-Assisted Diagnosis in Neurology Industrial Chain
8.2 AI-Assisted Diagnosis in Neurology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 AI-Assisted Diagnosis in Neurology Sales Model
8.5.2 Sales Channel
8.5.3 AI-Assisted Diagnosis in Neurology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. AI-Assisted Diagnosis in Neurology Market Trends
    Table 2. AI-Assisted Diagnosis in Neurology Market Drivers & Opportunity
    Table 3. AI-Assisted Diagnosis in Neurology Market Challenges
    Table 4. AI-Assisted Diagnosis in Neurology Market Restraints
    Table 5. Global AI-Assisted Diagnosis in Neurology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global AI-Assisted Diagnosis in Neurology Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies AI-Assisted Diagnosis in Neurology Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies AI-Assisted Diagnosis in Neurology Product Type
    Table 9. Key Companies Time to Begin Mass Production of AI-Assisted Diagnosis in Neurology
    Table 10. Global AI-Assisted Diagnosis in Neurology Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-Assisted Diagnosis in Neurology as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global AI-Assisted Diagnosis in Neurology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global AI-Assisted Diagnosis in Neurology Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global AI-Assisted Diagnosis in Neurology Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global AI-Assisted Diagnosis in Neurology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global AI-Assisted Diagnosis in Neurology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global AI-Assisted Diagnosis in Neurology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global AI-Assisted Diagnosis in Neurology Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global AI-Assisted Diagnosis in Neurology Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global AI-Assisted Diagnosis in Neurology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global AI-Assisted Diagnosis in Neurology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global AI-Assisted Diagnosis in Neurology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global AI-Assisted Diagnosis in Neurology Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global AI-Assisted Diagnosis in Neurology Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global AI-Assisted Diagnosis in Neurology Sales Value by Region (2019-2024) & (%)
    Table 27. Global AI-Assisted Diagnosis in Neurology Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions AI-Assisted Diagnosis in Neurology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions AI-Assisted Diagnosis in Neurology Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions AI-Assisted Diagnosis in Neurology Sales Value, (2025-2030) & (US$ Million)
    Table 31. BioMind Basic Information List
    Table 32. BioMind Description and Business Overview
    Table 33. BioMind AI-Assisted Diagnosis in Neurology Products, Services and Solutions
    Table 34. Revenue (US$ Million) in AI-Assisted Diagnosis in Neurology Business of BioMind (2019-2024)
    Table 35. BioMind Recent Developments
    Table 36. Arterys Basic Information List
    Table 37. Arterys Description and Business Overview
    Table 38. Arterys AI-Assisted Diagnosis in Neurology Products, Services and Solutions
    Table 39. Revenue (US$ Million) in AI-Assisted Diagnosis in Neurology Business of Arterys (2019-2024)
    Table 40. Arterys Recent Developments
    Table 41. Brain Scientific Basic Information List
    Table 42. Brain Scientific Description and Business Overview
    Table 43. Brain Scientific AI-Assisted Diagnosis in Neurology Products, Services and Solutions
    Table 44. Revenue (US$ Million) in AI-Assisted Diagnosis in Neurology Business of Brain Scientific (2019-2024)
    Table 45. Brain Scientific Recent Developments
    Table 46. Methinks Basic Information List
    Table 47. Methinks Description and Business Overview
    Table 48. Methinks AI-Assisted Diagnosis in Neurology Products, Services and Solutions
    Table 49. Revenue (US$ Million) in AI-Assisted Diagnosis in Neurology Business of Methinks (2019-2024)
    Table 50. Methinks Recent Developments
    Table 51. Neuro-AI Basic Information List
    Table 52. Neuro-AI Description and Business Overview
    Table 53. Neuro-AI AI-Assisted Diagnosis in Neurology Products, Services and Solutions
    Table 54. Revenue (US$ Million) in AI-Assisted Diagnosis in Neurology Business of Neuro-AI (2019-2024)
    Table 55. Neuro-AI Recent Developments
    Table 56. Key Raw Materials Lists
    Table 57. Raw Materials Key Suppliers Lists
    Table 58. AI-Assisted Diagnosis in Neurology Downstream Customers
    Table 59. AI-Assisted Diagnosis in Neurology Distributors List
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
    Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. AI-Assisted Diagnosis in Neurology Product Picture
    Figure 2. Global AI-Assisted Diagnosis in Neurology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global AI-Assisted Diagnosis in Neurology Sales Value (2019-2030) & (US$ Million)
    Figure 4. AI-Assisted Diagnosis in Neurology Report Years Considered
    Figure 5. Global AI-Assisted Diagnosis in Neurology Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by AI-Assisted Diagnosis in Neurology Revenue in 2023
    Figure 7. AI-Assisted Diagnosis in Neurology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Hardware Picture
    Figure 9. Software Picture
    Figure 10. Global AI-Assisted Diagnosis in Neurology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global AI-Assisted Diagnosis in Neurology Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Visualization Analysis
    Figure 13. Product Picture of Diagnoses
    Figure 14. Product Picture of Others
    Figure 15. Global AI-Assisted Diagnosis in Neurology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global AI-Assisted Diagnosis in Neurology Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America AI-Assisted Diagnosis in Neurology Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe AI-Assisted Diagnosis in Neurology Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific AI-Assisted Diagnosis in Neurology Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America AI-Assisted Diagnosis in Neurology Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa AI-Assisted Diagnosis in Neurology Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa AI-Assisted Diagnosis in Neurology Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions AI-Assisted Diagnosis in Neurology Sales Value (%), (2019-2030)
    Figure 28. United States AI-Assisted Diagnosis in Neurology Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States AI-Assisted Diagnosis in Neurology Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe AI-Assisted Diagnosis in Neurology Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe AI-Assisted Diagnosis in Neurology Sales Value by Application (%), 2023 VS 2030
    Figure 34. China AI-Assisted Diagnosis in Neurology Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
    Figure 36. China AI-Assisted Diagnosis in Neurology Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan AI-Assisted Diagnosis in Neurology Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan AI-Assisted Diagnosis in Neurology Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea AI-Assisted Diagnosis in Neurology Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea AI-Assisted Diagnosis in Neurology Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia AI-Assisted Diagnosis in Neurology Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia AI-Assisted Diagnosis in Neurology Sales Value by Application (%), 2023 VS 2030
    Figure 46. India AI-Assisted Diagnosis in Neurology Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India AI-Assisted Diagnosis in Neurology Sales Value by Type (%), 2023 VS 2030
    Figure 48. India AI-Assisted Diagnosis in Neurology Sales Value by Application (%), 2023 VS 2030
    Figure 49. AI-Assisted Diagnosis in Neurology Industrial Chain
    Figure 50. AI-Assisted Diagnosis in Neurology Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Secure Hospital Communications Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H6366
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Direct To Consumer Telehealth Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I2436
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Healthcare API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10N6171
Thu Sep 11 00:00:00 UTC 2025

Add to Cart